Retatrutide Dosing Explained (Doctor Breaks Down the Data)
Dr. Alex Tatem — Retatrutide Dosing Explained (Doctor Breaks Down the Data)
Channel: Dr. Alex Tatem · Our label: Clinician; paid clinician face of Superpower (disclosed) · Source: youtube.com/watch?v=83M6RWKjzQY
What this video covers
Right now, somewhere in America, a guy is reconstituting a vial of powder that he bought off a website that also sells him SARMMS and branded merch. He has no idea how many milligrams are actually in it, but his buddy at the gym said it had a solid COA for whatever that’s worth. And he’s about to inject the single most powerful weight loss drug humanity has ever produced into his stomach on purpose. Last week, it posted phase 3 numbers that made Trozepide look like a warm-up act, and it’s not even approved yet.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Last week, it posted phase 3 numbers that made Trozepide look like a warm-up act, and it’s not even approved yet.
- So today we’re talking dosing, what the trials actually did, what’s coming when this thing hits the market and carefully with a little lawyer sitting on my shoulder.
- And until that finishes and the FDA signs off, there is no legal pharma grade reatride.
- Retat true is still an investigational drug that is still in clinical trials and is not approved by the FDA for anyone for anything.
- We are whether we like it or not living through an unprecedented uncontrolled clinical trial that is happening at scale.
- Unlike the simaglutine tresepide shortage era where compoundingies had a legal lane, the FDA has said reatride cannot be legally compounded because no duh, there is no legitimate pharmacy version.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.